1311265-17-4 Usage
Uses
Used in Organic Synthesis:
Ethyl 1-((4-bromophenoxy)methyl)cyclopropanecarboxylate is used as a reagent or building block in organic synthesis for the production of more complex molecules. Its unique structure, including the cyclopropane ring and the 4-bromophenoxy methyl group, allows for versatile chemical reactions and the formation of a wide range of compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, ethyl 1-((4-bromophenoxy)methyl)cyclopropanecarboxylate may be used as a precursor or intermediate in the synthesis of pharmaceutical compounds. Its structural features can be exploited to develop new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
Ethyl 1-((4-bromophenoxy)methyl)cyclopropanecarboxylate may also find applications in the agrochemical industry, where it could be used as a starting material for the synthesis of agrochemicals such as pesticides or herbicides. Its unique structure may contribute to the development of novel and effective agrochemicals.
Used in Materials Science:
In the field of materials science, ethyl 1-((4-bromophenoxy)methyl)cyclopropanecarboxylate could be utilized in the development of new materials with specific properties. Its cyclopropane ring and functional groups may be incorporated into polymers, coatings, or other materials to enhance their performance or introduce new functionalities.
Check Digit Verification of cas no
The CAS Registry Mumber 1311265-17-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,1,2,6 and 5 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1311265-17:
(9*1)+(8*3)+(7*1)+(6*1)+(5*2)+(4*6)+(3*5)+(2*1)+(1*7)=104
104 % 10 = 4
So 1311265-17-4 is a valid CAS Registry Number.
1311265-17-4Relevant academic research and scientific papers
S PIRO [CHROMAN - 4, 4 ' - IMIDAZOL] ONES AS BETA - SECRETASE INHIBITORS
-
, (2011/06/26)
The invention provides novel spirochroman compounds of Formulas I and II that inhibit β-secretase cleavage of APP and are useful as therapeutic agents for treating neurodegenerative diseases.
